首页|真实世界数据在创新药医保准入中的应用情境及路径

真实世界数据在创新药医保准入中的应用情境及路径

扫码查看
我国创新药医保准入进程正在逐步加快,但准入决策风险也随之上升.规范应用真实世界数据可以为医保准入评估提供重要证据,从而降低决策风险.本文分析真实世界数据的优劣势及其在医保准入中的应用情境,梳理国内外现有政策框架和指南规范,提出真实世界数据在我国创新药医保准入中的研究规范和应用路径,为真实世界数据研究应用于医保准入提供参考.
Application Scenarios and Paths of Real-World Data in Innovative Drug Medical Insurance Admission
The process of innovative drug medical insurance admission in China is gradually accelerating,but the risk of admission decision-making is also increasing.Standardizing the application of real-world data can provide important evidence for medical insurance admission assessment,thereby reducing decision-making risks.This article analyzes the advantages and disadvantages of real-world data and application scenarios in medical insurance access,summarizes current policy frameworks and guidelines at home and abroad,and proposes research standards and application paths for real-world data in China's innovative drug medical insurance access,providing references for the application of real-world data research in medical insurance access.

real-world datainnovative drugsmedical insurance admissionapplication scenariosresearch standardapplication path

李芬、刘宇晗、胡嘉浩、朱碧帆、侯晓慧、范珂也、金春林

展开 >

上海市卫生和健康发展研究中心 上海 200040

上海市卫健委财务管理事务中心 上海 200040

中国药科大学 南京 210009

真实世界数据 创新药 医保准入 应用情境 研究规范 应用路径

2024

中国医疗保险
中国医疗保险研究会

中国医疗保险

影响因子:0.492
ISSN:1674-3830
年,卷(期):2024.(11)